Non-ownership Filings
| Admission to trading on OTCQB in the US | Apr. 21, 2026 |
| EMI Share Option Scheme | Apr. 15, 2026 |
| Trading to commence on the OTCQB in the US | Apr. 14, 2026 |
| £4.8m contracts awarded | Mar. 30, 2026 |
| Half-year Financial Report | Mar. 17, 2026 |
| $2.5m Contract for clinical self-test development | Mar. 12, 2026 |
| Trading on the OTCQB Venture Market in the US | Mar. 10, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Aug. 14, 2025 |
| Award of Options under LTIP | May. 02, 2025 |
| TR-1 | Aug. 19, 2024 |
| TR-1 | Aug. 19, 2024 |
| TR-1 | Aug. 19, 2024 |
| Director/PDMR Shareholding | Oct. 25, 2023 |
| Award of Options under LTIP | Oct. 24, 2023 |